Intelligent Bio Solutions Inc.

INBS ·Healthcare, Medical Devices, United States
Financial Statements › Balance Sheet
Annual Quarterly

Balance Sheet

Line Item FY2026 FY2025 FY2024 FY2023 FY2022 FY2021 FY2020
Assets
Cash & Equivalents $4.0M $1.0M $6.3M $1.5M $8.2M $12.6M $427.3K
Accounts Receivable $848.5K $594.6K $429.7K $293.9K — — —
Inventory $418.6K $635.2K $777.5K $979.9K — — —
Total Current Assets $7.1M $4.1M $8.5M $3.9M $10.9M $18.2M $2.3M
Property, Plant & Equipment $294.4K $251.3K $565.9K $690.2K $391.4K — —
Goodwill — — — $3.8M — — —
Intangible Assets (Excl. Goodwill) $2.8M $3.8M $4.4M $5.3M — — —
Total Assets $11.9M $8.2M $13.8M $10.4M $12.4M $21.9M $2.5M
Liabilities
Accounts Payable $712.4K $897.3K $1.7M $2.6M $1.6M $1.5M $787.5K
Total Current Liabilities $4.9M $5.4M $5.5M $5.9M $4.7M $3.7M $7.7M
Long-Term Debt — — $1.7M — — — —
Total Liabilities $6.7M $5.4M $5.6M $6.7M $5.8M $6.9M $7.7M
Stockholders' Equity
Retained Earnings $-75.0M $-62.5M $-52.0M $-41.8M $-31.2M $-22.9M $-15.8M
Total Stockholders' Equity $5.5M $3.0M $8.3M $3.8M $6.6M $15.1M $-5.2M